Endogenous and exogenous thioredoxin 1 prevents goblet cell hyperplasia in a chronic antigen exposure asthma model

Allergology International

Volumn 58, Issue 3, 2009, Pages 403-410

  Imaoka, Haruki ^a   Hoshino, Tomoaki ^a   Okamoto, Masaki ^a   Sakazaki, Yuki ^a   Sawada, Masanori ^a   Takei, Satoko ^a   Kinoshita, Takashi ^a   Kawayama, Tomotaka ^a   Kato, Seiya ^b   Aizawa, Hisamichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Airway remodeling; Asthma; Goblet cell; Thioredoxin

Indexed keywords

ANTIASTHMATIC AGENT; ANTIGEN; OVALBUMIN; RECOMBINANT PROTEIN; RECOMBINANT THIOREDOXIN 1; THIOREDOXIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL HYPERPLASIA; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GOBLET CELL; LUNG ALVEOLUS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SENSITIZATION; TRANSGENE; WILD TYPE;

EID: 70450187800     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.09-OA-0086     Document Type: Article

References (43)

1. Barnes PJ. Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine Growth Factor Rev 2003;14:511-522 (Pubitemid 37296024)
2. Barnes PJ. Endogenous inhibitory mechanisms in asthma. Am J Respir Crit Care Med 2000;161:S176-81.
3. Ebina M, Takahashi T, Chiba T, Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis 1993;148:720-726 (Pubitemid 23263786)
4. Payne DN, Rogers AV, Adelroth E et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003;167:78-82. (Pubitemid 36015921)
5. Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003;167: 1360-1368 (Pubitemid 36609720)
6. Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992;101:916-921
7. Shimura S, Andoh Y, Haraguchi M, Shirato K. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J 1996; 9:1395-1401 (Pubitemid 26233780)
8. Carroll N, Carello S, Cooke C, James A. Airway structure and inflammatory cells in fatal attacks of asthma. Eur Respir J 1996;9:709-715 (Pubitemid 26167875)
9. Rogers DF. Airway goblet cell hyperplasia in asthma: Hypersecretory and anti-inflammatory? Clin Exp Allergy 2002;32:1124-1127
10. Yamauchi K, Piao HM, Nakadate T et al. Progress in allergy signal research on mast cells: The role of histamine in goblet cell hyperplasia in allergic airway inflammation - a study using the hdc knockout mouse. J Pharmacol Sci 2008;106:354-360
11. Southam DS, Ellis R, Wattie J, Glass W, Inman MD. Goblet cell rebound and airway dysfunction with corticosteroid withdrawal in a mouse model of asthma. Am J Respir Crit Care Med 2008;178:1115-1122
12. Arner ES, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 2000; 267:6102-6109
13. Nakamura T, Nakamura H, Hoshino T, Ueda S, Wada H, Yodoi J. Redox regulation of lung inflammation by thioredoxin. Antioxid Redox Signal 2005;7:60-71. (Pubitemid 40187925)
14. Holmgren A. Thioredoxin. Annu Rev Biochem 1985;54: 237-271
15. Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 1997;15:351-369
16. Okamoto M, Kato S, Oizumi K et al. Interleukin 18 (IL-18) in synergy with IL-2 induces lethal lung injury in mice: A potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia. Blood 2002;99:1289-1298 (Pubitemid 34547083)
17. Hoshino T, Nakamura H, Okamoto M et al. Redox-active protein thioredoxin prevents proinflammatory cytokineor bleomycin-induced lung injury. Am J Respir Crit Care Med 2003;168:1075-1083 (Pubitemid 37338936)
18. Kinoshita T, Hoshino T, Imaoka H et al. Thioredoxin prevents the development and progression of elastaseinduced emphysema. Biochem Biophys Res Commun 2007; 354:712-719 (Pubitemid 46186243)
19. Ichiki H, Hoshino T, Kinoshita T et al. Thioredoxin suppresses airway hyperresponsiveness and airway inflammation in asthma. Biochem Biophys Res Commun 2005; 334:1141-1148 (Pubitemid 41074693)
20. Imaoka H, Hoshino T, Takei S et al. Effects of thioredoxin on established airway remodeling in a chronic antigen exposure asthma model. Biochem Biophys Res Commun 2007;360:525-530 (Pubitemid 47048131)
21. Komori M, Inoue H, Matsumoto K et al. Paf mediates cigarette smoke-induced goblet cell metaplasia in guinea pig airways. Am J Physiol Lung Cell Mol Physiol 2001;280: L436-41.
22. Kobayashi M, Tanaka A, Hayashi Y, Shimamura S. The CMV enhancer stimulates expression of foreign genes from the human EF-1 alpha promoter. Anal Biochem 1997;247:179-181 (Pubitemid 27161515)
23. Gill DR, Smyth SE, Goddard CA et al. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Ther 2001;8:1539-1546
24. Bowler RP, Crapo JD. Oxidative stress in airways: Is there a role for extracellular superoxide dismutase? Am J Respir Crit Care Med 2002;166:S38-43.
25. Hoshino T, Okamoto M, Takei S, Sakazaki Y, Iwanaga T, Aizawa H. Redox-regulated mechanisms in asthma. Antioxid Redox Signal 2008;10:769-783
26. Voynow JA, Fischer BM, Malarkey DE et al. Neutrophil elastase induces mucus cell metaplasia in mouse lung. Am J Physiol Lung Cell Mol Physiol 2004;287:L1293-302.
27. Harkema JR, Hotchkiss JA. Ozone- and endotoxin-induced mucous cell metaplasias in rat airway epithelium: Novel animal models to study toxicant-induced epithelial transformation in airways. Toxicol Lett 1993;68:251-63.
28. Krishna MT, Madden J, Teran LM et al. Effects of 0.2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid and bronchial mucosa of healthy subjects. Eur Respir J 1998;11:1294-1300
29. Rennard SI. Repair mechanisms in asthma. J Allergy Clin Immunol 1996;98:S278-86.
30. Dabbagh K, Takeyama K, Lee HM, Ueki IF, Lausier JA, Nadel JA. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol 1999;162: 6233-6237 (Pubitemid 29314987)
31. Longphre M, Li D, Gallup M et al. Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest 1999;104:1375-1382
32. Temann UA, Prasad B, Gallup MWet al. A novel role for murine IL-4 in vivo: Induction of MUC5AC gene expression and mucin hypersecretion. Am J Respir Cell Mol Biol 1997;16:471-478 (Pubitemid 127497474)
33. Zhu Z, Homer RJ, Wang Z et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-788 (Pubitemid 29152623)
34. Nakamura H, Herzenberg LA, Bai J et al. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc Natl Acad Sci USA 2001;98:15143-15148 (Pubitemid 34013983)
35. Saitoh M, Nishitoh H, Fujii M et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. Embo J 1998;17:2596-2606 (Pubitemid 28221195)
36. Ueno M, Masutani H, Arai RJ et al. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem1999;274:35809-35815
37. Maekawa A, Schmidt B, Fazekas de St Groth B, Sanejouand YH, Hogg PJ. Evidence for a domain-swapped CD4 dimer as the coreceptor for binding to class II MHC. J Immunol 2006;176:6873-6878 (Pubitemid 43787868)
38. Ordonez CL, Khashayar R, Wong HH et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med 2001;163:517-523 (Pubitemid 32158539)
39. Nakanishi A, Morita S, Iwashita H et al. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci USA 2001;98:5175-5180 (Pubitemid 32397102)
40. Global Initiative for Asthma. Global Strategy for Asthma Management and Preventation. Revised 2008. Available from: http://www.ginasthma.com.
41. Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF, for Asthma and Allergy Research Group of the National Heart and Lung Institute. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003;22:478-483
42. Busse W, Banks-Schlegel S, Noel P, Ortega H, Taggart V, Elias J, for NHLBI Working Group. Future research directions in asthma: An nhlbi working group report. Am J Respir Crit Care Med 2004;170:683-690
43. Inman M. Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy? Eur Respir J 2004;24:1-2. (Pubitemid 39029061)